Understanding how immune cells affect the repair of nerve insulation in the brain
Microglial impact on remyelination
This study is looking at how certain immune cells in the brain help repair damage caused by multiple sclerosis, with the hope of finding new ways to improve treatments for people living with this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-10834169 on NIH RePORTER |
What this research studies
This research investigates the role of microglial cells, a type of immune cell in the brain, in the process of remyelination, which is crucial for restoring brain function after damage caused by conditions like multiple sclerosis. The researchers are using advanced techniques, including single-cell RNA sequencing, to analyze how different microglial subsets influence the maturation of oligodendrocytes, the cells responsible for producing myelin. By studying these interactions in models that mimic the disease environment, the research aims to identify potential therapeutic targets to enhance remyelination. Patients may benefit from insights that could lead to new treatments for demyelinating diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with multiple sclerosis or other demyelinating conditions.
Not a fit: Patients with conditions unrelated to demyelination or those who are not diagnosed with multiple sclerosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that enhance nerve repair and improve outcomes for patients with multiple sclerosis.
How similar studies have performed: Other research has shown promise in understanding the role of immune cells in remyelination, but this specific approach using patient-derived antibodies is relatively novel.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Macklin, Wendy B — University of Colorado Denver
- Study coordinator: Macklin, Wendy B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.